Outcome of eribulin as a late treatment line for Thai metastatic breast cancer patients

BACKGROUND: We report the safety and efficacy of eribulin as a late treatment line in Thai metastatic breast cancer (MBC) patients. PATIENTS AND METHODS: A total of 30 MBC patients treated with eribulin between January 2014 and January 2017 were retrospectively analyzed. The patients were scheduled...

Descripción completa

Detalles Bibliográficos
Autores principales: Ditsatham, Chagkrit, Chitapanarux, Imjai, Somwangprasert, Areewan, Watcharachan, Kirati, Wongmaneerung, Panchaporn, Charoentum, Chaiyut, Chewaskulyong, Busyamas, Chakrabandhu, Somvilai, Onchan, Wimrak, Teeyasuntranonn, Anongnart, Sripan, Patumrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074808/
https://www.ncbi.nlm.nih.gov/pubmed/30104885
http://dx.doi.org/10.2147/OTT.S166399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074808/
https://www.ncbi.nlm.nih.gov/pubmed/30104885
http://dx.doi.org/10.2147/OTT.S166399

Ejemplares similares